Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Allergy ; 73(5): 1032-1040, 2018 05.
Article in English | MEDLINE | ID: mdl-29171882

ABSTRACT

BACKGROUND: Accurate allergen quantification is needed to document the consistency of allergen extracts used for immunotherapy. Herein, we characterize the epitope specificities of two monoclonal antibodies used in an ELISA for the quantification of the major birch pollen allergen Bet v 1, established as a reference by the BSP090 European project. METHODS: The ability of mAbs 5B4 and 6H4 to recognize Bet v 1 isoforms was addressed by immunochromatography. The capacity of each mAb to compete with patients' IgE for binding to Bet v 1 was measured by ELISA inhibition. Epitope mapping was performed by pepscan analysis, site-directed mutagenesis, and hydrogen/deuterium exchange-mass spectrometry. RESULTS: The 5B4 epitope corresponds to a peptide sequence (I56-K68) overlapping with the binding sites of patients' serum IgEs. Mutation of residues P59, E60, and K65 abolishes 5B4 binding to Bet v 1 and reduces the level of IgE recognition. In contrast, 6H4 recognizes a conformational epitope lying opposite to the 5B4 binding site, involving residues located in segments I44-K55 and R70-F79. Substitution of E45 reduces the binding capacity of 6H4, confirming that it is critical for the interaction. Both mAbs interact with >90% of Bet v 1 content present in the birch pollen extract, while displaying a weak cross-reactivity with other allergens of the PR-10 family. CONCLUSIONS: MAbs 5B4 and 6H4 recognize structurally distinct epitopes present in the vast majority of Bet v 1 isoforms. These results support the relevance as a reference method of the Bet v 1-specific quantitative ELISA adopted by the European Pharmacopoeia.


Subject(s)
Antibodies, Monoclonal/immunology , Antibody Specificity , Antigens, Plant/immunology , Desensitization, Immunologic/standards , Epitope Mapping/methods , Allergens/immunology , Epitope Mapping/standards , Humans , Protein Isoforms
2.
Adv Mater ; 32(29): e2000952, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32468648

ABSTRACT

Lithium (Li) metal electrode cannot endure elevated temperature (e.g., >200 °C) with the regular battery configuration due to its low melting point (180.5 °C) and high reactivity, which restricts its application in high-temperature Li metal batteries for energy storage and causes safety concerns for regular ambient-temperature Li metal batteries. Herein, this work reports a Li5 B4 /Li composite featuring a 3D Li5 B4 fibrillar framework filled with metallic Li, which maintains its initial structure at 325 °C in Ar atmosphere without leakage of the liquid Li. The capillary force caused by the porous structure of the Li4 B5 fibrillar framework, together with its lithiophilic surface, restricts the leakage of liquid metallic Li and enables good thermal tolerance of the Li5 B4 /Li composite. Thus, it can be facilely operated for rechargeable high-temperature Li metal batteries. Li5 B4 /Li electrodes are coupled with a garnet-type ceramic electrolyte (Li6.5 La3 Zr0.5 Ta1.5 O12 ) to fabricate symmetric cells, which exhibit stable Li stripping/plating behaviors with low overpotential of ≈6 mV at 200 °C using a regular sandwich-type cell configuration. This work affords new insights into realizing a stable Li metal anode for high-temperature Li metal batteries with a simple battery configuration and high safety, which is different from traditional molten-salt Li metal batteries using a pristine metallic Li anode.

SELECTION OF CITATIONS
SEARCH DETAIL